1468. PCV13 Serotype Trends Over Time in Pneumococcal Community Acquired Pneumonia: Which Method(s) Work Best?

BACKGROUND: Recent studies have shown that a 13-valent pneumococcal conjugate vaccine (PCV13) was effective at preventing vaccine-type pneumococcal community acquired pneumonia (CAP(Spn)) in healthy adults. With the anticipated herd immunity from routine infant immunization with PCV13 used since 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Leblanc, Jason, Elsherif, May, Ye, Lingyun, Mackinnon-Cameron, Donna, Ambrose, Ardith, Hatchette, Todd, Martin, Irene, Andrew, Melissa K, Boivin, Guy, Bowie, William R, Green, Karen, Johnstone, Jennie, Loeb, Mark, Mccarthy, Anne, McGeer, Allison, Semret, Makeda, Trottier, Sylvie, Valiquette, Louis, Webster, Duncan, McNeil, Shelly A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253164/
http://dx.doi.org/10.1093/ofid/ofy210.1298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253164/
http://dx.doi.org/10.1093/ofid/ofy210.1298

Ejemplares similares